Page last updated: 2024-11-04

linsidomine and Liver Cirrhosis, Alcoholic

linsidomine has been researched along with Liver Cirrhosis, Alcoholic in 1 studies

linsidomine: RN given refers to parent cpd; structure

Liver Cirrhosis, Alcoholic: FIBROSIS of the hepatic parenchyma due to chronic excess ALCOHOL DRINKING.

Research Excerpts

ExcerptRelevanceReference
"The pharmacokinetics of molsidomine were investigated in six healthy volunteers and in seven patients with alcoholic cirrhosis."5.07Pharmacokinetics of molsidomine and its active metabolite, linsidomine, in patients with liver cirrhosis. ( Advenier, C; Andrieu, J; Cordonnier, P; Doll, J; Dutot, C; Grandjean, N; Pays, M; Spreux-Varoquaux, O, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spreux-Varoquaux, O1
Doll, J1
Dutot, C1
Grandjean, N1
Cordonnier, P1
Pays, M1
Andrieu, J1
Advenier, C1

Trials

1 trial available for linsidomine and Liver Cirrhosis, Alcoholic

ArticleYear
Pharmacokinetics of molsidomine and its active metabolite, linsidomine, in patients with liver cirrhosis.
    British journal of clinical pharmacology, 1991, Volume: 32, Issue:3

    Topics: Adult; Humans; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Molsidomine; Reference Values

1991